Apokyn

Product manufactured by Us Worldmeds, Llc

Application Nr Approved Date Route Status External Links
NDA021264 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Apokyn (Apomorphine Hydrochloride Injection) Is Indicated For The Acute, Intermittent Treatment Of Hypomobility, "off" Episodes ("end-Of-Dose Wearing Off" And Unpredictable "on/off" Episodes) In Patients With Advanced Parkinson's Disease. Apokyn Has Been Studied As An Adjunct To Other Medications [See Clinical Studies (14) ] . Apokyn Is A Non-Ergoline Dopamine Agonist Indicated For The Acute, Intermittent Treatment Of Hypomobility, "off" Episodes ("end-Of-Dose Wearing Off" And Unpredictable "on/off" Episodes) Associated With Advanced Parkinson's Disease ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Apomorphine Hydrochloride APOMORPHINE HYDROCHLORIDE ZINC9073

Comments